Neuronetics, Inc. (STIM)
NASDAQ: STIM · Real-Time Price · USD
1.315
-0.065 (-4.71%)
Mar 9, 2026, 1:57 PM EDT - Market open
Neuronetics Employees
Neuronetics had 716 employees as of December 31, 2024. The number of employees increased by 513 or 252.71% compared to the previous year.
Employees
716
Change (1Y)
513
Growth (1Y)
252.71%
Revenue / Employee
$181,387
Profits / Employee
-$62,154
Market Cap
90.06M
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| Treace Medical Concepts | 477 |
| Pulmonx | 291 |
| Xtant Medical Holdings | 232 |
| Apyx Medical | 220 |
| Baird Medical Investment Holdings | 143 |
| MaxCyte | 114 |
| Hyperfine | 111 |
| Picard Medical | 75 |
STIM News
- 26 days ago - Neuronetics Announces Selected Preliminary Unaudited Fourth Quarter and Full Year 2025 Financial Results - GlobeNewsWire
- 3 months ago - Neuronetics to Participate at the Piper Sandler 37th Annual Healthcare Conference - GlobeNewsWire
- 3 months ago - Top 3 Health Care Stocks Which Could Rescue Your Portfolio In November - Benzinga
- 4 months ago - TRICARE West Expands NeuroStar® TMS Coverage to Include Adolescents Aged 15+ Struggling with Depression - GlobeNewsWire
- 4 months ago - Neuronetics, Inc. (STIM) Q3 2025 Earnings Call Transcript - Seeking Alpha
- 4 months ago - Neuronetics Reports Third Quarter 2025 Financial and Operating Results and Announces CEO Transition Plan - GlobeNewsWire
- 4 months ago - Neuronetics Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewsWire
- 4 months ago - Neuronetics Announces Three-Year Exclusive Partnership with Elite DNA Behavioral Health to Expand NeuroStar Access and Operational Excellence - GlobeNewsWire